FY23 Research

Cinnamon Bidwell, PhD,
Institute of Cognitive Science Faculty, Associate Professor, University of Colorado Boulder

Duncan Mackie, PhD,
Director of Pharmacology & Experimental Therapeutics, MedPharm Holdings

This groundbreaking research is shedding light on the accuracy of product labeling in Colorado.

In Colorado, all cannabis products must carry state-mandated labels detailing the potency […]

Kent Hutchison, PhD
Institute of Cognitive Science Affiliated Faculty & Professor, University of Colorado Boulder

Traumatic brain injury (TBI) represents a major public health burden due to chronic neuropsychiatric sequelae (emotional, physical and cognitive) that negatively affect vocational activities, interpersonal relationships and independent living. Responses of these chronic symptoms to any particular treatment are both […]

Cinnamon Bidwell, PhD,
Institute of Cognitive Science Faculty, Assistant Professor, University of Colorado Boulder

Duncan Mackie, PhD,
Director of Pharmacology & Experimental Therapeutics, MedPharm Holdings

Our research group has a longstanding interest in the activity of cannabinoids for the treatment of inflammatory neurological diseases such as Alzheimer’s disease. The purpose of this proposal is to […]

Christopher Lowry, PhD
Associate Professor, Integrative Physiology, University of Colorado Boulder

Over 50% of children with autism spectrum disorder (ASD) show sub-clinical epileptic spikes by adolescence and 5-40% develop chronic epilepsy. Similarly, approximately 30% of children with epilepsy are also diagnosed with ASD. As a likely etiology, the role of inflammation in epilepsy is under […]